Cargando…

Progestins: Pro-senescence therapy for ovarian cancer?

Detalles Bibliográficos
Autores principales:	Oesterreich, Steffi, Edwards, Robert, Vlad, Anda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Cell Cycle News & Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713123/ https://www.ncbi.nlm.nih.gov/pubmed/23708445 http://dx.doi.org/10.4161/cc.25072

Ejemplares similares

Progesterone and FOXO1 signaling: Harnessing cellular senescence for the treatment of ovarian cancer
por: Brosens, Jan J., et al.
Publicado: (2013)

Cancers co-opt cohabitants’ catabolism: Autophagy and senescence in the tumor stroma
por: Zealley, Ben J.E., et al.
Publicado: (2012)

WIP1 and senescence: Oxygen matters
por: Olcina, Monica M, et al.
Publicado: (2014)

Complete senescence: RB and PML share the task
por: Vernier, Mathieu, et al.
Publicado: (2014)

A critical role for TORC1 in cellular senescence
por: Denchi, Eros Lazzerini
Publicado: (2012)

Dissecting the role of mTOR complexes in cellular senescence
por: Serrano, Manuel
Publicado: (2012)

Senescence-associated lysosomal α-L-fucosidase (SA-α-Fuc): A sensitive and more robust biomarker for cellular senescence beyond SA-β-Gal
por: Singh, Madhurendra, et al.
Publicado: (2013)

BMPs morph into new roles in ovarian cancer
por: McLean, Karen, et al.
Publicado: (2013)

Tetraploid cancer cell precursors in ovarian carcinoma
por: Castedo, Maria, et al.
Publicado: (2012)

miR-141, a new player, joins the senescence orchestra
por: Itahana, Yoko, et al.
Publicado: (2013)

INK4a/ARF-dependent senescence upon persistent replication stress
por: O’Driscoll, Mark
Publicado: (2013)

MRE11 and ATM AKTivate pro-survival signaling
por: Golding, Sarah E., et al.
Publicado: (2011)

CTGF-mediated autophagy-senescence transition in tumor stroma promotes anabolic tumor growth and metastasis
por: Prabhu, Varun V., et al.
Publicado: (2012)

Short-circuiting the cell cycle for cancer therapy
por: Gillespie, David A.
Publicado: (2012)

Hot and toxic: Hyperthermia and anti-mitotic drugs in cancer therapy
por: Barlev, Nickolai A
Publicado: (2013)

Cyclin-dependent kinase 4/6 inhibition in cancer therapy
por: Johnson, Neil, et al.
Publicado: (2012)

Sizing up circulating tumor cells for personalized therapy
por: Matthew, Elizabeth M, et al.
Publicado: (2013)

3D culture adds an extra dimension to targeted epigenetic therapies
por: Ozes, Ali R, et al.
Publicado: (2013)

Fenofibrate triggers apoptosis of glioblastoma cells in vitro: New insights for therapy
por: Giordano, Antonio, et al.
Publicado: (2012)

Wee1-Hsp90 inhibitor combination treatment: Molecular therapy with potentially broad applicability
por: Lokeshwar, Vinata B.
Publicado: (2012)

Vitamin D and cancer
por: Verstuyf, Annemieke, et al.
Publicado: (2013)

From photomorphogenesis to cancer: A CSN journey
por: Salmena, Leonardo, et al.
Publicado: (2013)

Compensation, crosstalk and sequestering: The currency of checkpoints in cancer
por: Kaufmann, William K., et al.
Publicado: (2013)

Milking the stroma in triple-negative breast cancer
por: Thompson, Alastair M., et al.
Publicado: (2012)

On the connections between cancer stem cells and EMT
por: Cioce, Mario, et al.
Publicado: (2012)

Doubling the deck: Tetraploidy induces chromosome shuffling and cancer
por: Nicholson, Joshua M., et al.
Publicado: (2012)

Metformin is synthetically lethal with glucose withdrawal in cancer cells
por: Khurana, Ashwani, et al.
Publicado: (2012)

Differences in regulation and function of E-cyclins in human cancer cells
por: Geng, Yan, et al.
Publicado: (2013)

Mesenchymal traits and cancer stem cells in mammospheres: Chicken or egg?
por: Kohandel, Mohammad
Publicado: (2012)

Potentially novel options for treatment of HPV-attributable head and neck cancer
por: Brakenhoff, Ruud H.
Publicado: (2013)

A new connection between VHL and cancer threads through progerin
por: Kennedy, Brian K
Publicado: (2013)

GSK-3β: A key regulator of breast cancer drug resistance
por: Martelli, Alberto M, et al.
Publicado: (2014)

Control of cancer-associated fibroblast function by oxidative stress: A new piece in the puzzle
por: Scholer-Dahirel, Alix, et al.
Publicado: (2013)

Carbonic anhydrase 9 (CA9) and redox signaling in cancer-associated fibroblasts: Therapeutic implications
por: Chadwick, Amy L, et al.
Publicado: (2013)

MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment
por: Mori, Federica, et al.
Publicado: (2013)

Lin28 and HER2: Two stem cell regulators conspire to drive aggressive breast cancer
por: Malik, Fayaz, et al.
Publicado: (2012)

Setting the stage for cohesion establishment by the replication fork
por: Bharti, Sanjay Kumar, et al.
Publicado: (2012)

PP2A(Cdc55/B55), a possible therapeutic target in cyclin D1-dependent cancers
por: Noguchi, Eishi
Publicado: (2013)

The Herculean task of killing cancer cells: Suppression of FOXO3A in acute leukemia involves a hydra of multiple survival kinases
por: Ruvolo, Peter P.
Publicado: (2012)

A novel link between p53 and ROS
por: He, Zhaoyue, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_29r4dfrnboonv32jlj8loqlr7b